{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:03:21Z","timestamp":1771063401701,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,14]]},"DOI":"10.7759\/cureus.103578","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T09:07:34Z","timestamp":1771060054000},"source":"Crossref","is-referenced-by-count":0,"title":["Fat Embolization Syndrome in Sickle Cell Disease: A Case Report"],"prefix":"10.7759","author":[{"given":"Narjis","family":"AlQassab","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara S","family":"Radhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatema A","family":"Alnashaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmood B","family":"Dhaif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali  M","family":"Haider Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulrahman","family":"Al-Majmuei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/0971-5916.90984","article-title":"Sickle cell disease in Middle East Arab countries","volume":"134","author":"El-Hazmi MA","year":"2011","unstructured":"El-Hazmi MA, Al-Hazmi AM, Warsy AS. Sickle cell disease in Middle East Arab countries. Indian J Med Res. 2011, 134:597-610. 10.4103\/0971-5916.90984","journal-title":"Indian J Med Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/medicina62010172","article-title":"Pharmacogenomics and opioid efficacy in sickle cell disease","volume":"62","author":"Elshaikh RH","year":"2026","unstructured":"Elshaikh RH, Babker AM, Hussein SE, Ahmed KA, Sah AK, Alfeel AH. Pharmacogenomics and opioid efficacy in sickle cell disease. Medicina (Kaunas). 2026, 62:172. 10.3390\/medicina62010172","journal-title":"Medicina (Kaunas)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2012.03.001","article-title":"Cerebral fat embolism syndrome in sickle cell anaemia\/\u03b2-thalassemia: importance of susceptibility-weighted MRI","volume":"67","author":"Mossa-Basha M","year":"2012","unstructured":"Mossa-Basha M, Izbudak I, Gurda GT, Aygun N. Cerebral fat embolism syndrome in sickle cell anaemia\/\u03b2-thalassemia: importance of susceptibility-weighted MRI. Clin Radiol. 2012, 67:1023-6. 10.1016\/j.crad.2012.03.001","journal-title":"Clin Radiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000000443","article-title":"Sickle cell disease, fat embolism syndrome, and \"starfield\" pattern on MRI","volume":"8","author":"Kang JH","year":"2018","unstructured":"Kang JH, Hargett CW, Sevilis T, Luedke M. Sickle cell disease, fat embolism syndrome, and \"starfield\" pattern on MRI. Neurol Clin Pract. 2018, 8:162-4. 10.1212\/CPJ.0000000000000443","journal-title":"Neurol Clin Pract"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-11983-y","article-title":"Clinical, laboratory, radiological features, and outcome of acute fat embolism syndrome in sickle cell disease","volume":"15","author":"Salam A","year":"2025","unstructured":"Salam A, Sameer R, Eiman AA, et al.. Clinical, laboratory, radiological features, and outcome of acute fat embolism syndrome in sickle cell disease. Sci Rep. 2025, 15:27523. 10.1038\/s41598-025-11983-y","journal-title":"Sci Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9113601","article-title":"Fat embolism syndrome in sickle cell disease","volume":"9","author":"Tsitsikas DA","year":"2020","unstructured":"Tsitsikas DA, Vize J, Abukar J. Fat embolism syndrome in sickle cell disease. J Clin Med. 2020, 9:3601. 10.3390\/jcm9113601","journal-title":"J Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4314\/ahs.v20i1.45","article-title":"Comparative study of hypercoagulability change in steady state and during vaso-occlusive crisis among Sudanese patients living with sickle cell disease","volume":"20","author":"Mohamed EA","year":"2020","unstructured":"Mohamed EA, Elgari MM, Babker AM, Waggiallah HA. Comparative study of hypercoagulability change in steady state and during vaso-occlusive crisis among Sudanese patients living with sickle cell disease. Afr Health Sci. 2020, 20:392-6. 10.4314\/ahs.v20i1.45","journal-title":"Afr Health Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.77499","article-title":"Indications for blood transfusion and exchange transfusion in sickle cell disease: a single center experience","volume":"17","author":"Alsharari E","year":"2025","unstructured":"Alsharari E, Al Enazi A, Hanafy E, Mustafa M, Abufara F, Altoonisi MM. Indications for blood transfusion and exchange transfusion in sickle cell disease: a single center experience. Cureus. 2025, 17:e77499. 10.7759\/cureus.77499","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(74)91639-0","article-title":"Assessment of coma and impaired consciousness","volume":"304","author":"Teasdale G","year":"1974","unstructured":"Teasdale G, Jennett B. Assessment of coma and impaired consciousness. The Lancet. 1974, 304:81-4. 10.1016\/s0140-6736(74)91639-0","journal-title":"The Lancet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jointm.2021.11.004","article-title":"Septic cardiomyopathy: diagnosis and management","volume":"2","author":"Boissier F","year":"2022","unstructured":"Boissier F, Aissaoui N. Septic cardiomyopathy: diagnosis and management. J Intensive Med. 2022, 2:8-16. 10.1016\/j.jointm.2021.11.004","journal-title":"J Intensive Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.727","article-title":"Successful outcome of three patients with sickle-cell disease and fat embolism syndrome treated with intensive exchange transfusion","volume":"5","author":"Greaves P","year":"2017","unstructured":"Greaves P, Mathew V, Peters C, Rowe S, Amos RJ, Tsitsikas DA. Successful outcome of three patients with sickle-cell disease and fat embolism syndrome treated with intensive exchange transfusion. Clin Case Rep. 2017, 5:39-43. 10.1002\/ccr3.727","journal-title":"Clin Case Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2017160085","article-title":"Cytotoxic lesions of the corpus callosum that show restricted diffusion: mechanisms, causes, and manifestations","volume":"37","author":"Starkey J","year":"2017","unstructured":"Starkey J, Kobayashi N, Numaguchi Y, Moritani T. Cytotoxic lesions of the corpus callosum that show restricted diffusion: mechanisms, causes, and manifestations. Radiographics. 2017, 37:562-76. 10.1148\/rg.2017160085","journal-title":"Radiographics"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5057624","article-title":"Fat embolism and nonconvulsive status epilepticus","volume":"2018","author":"Olivera Arencibia Y","year":"2018","unstructured":"Olivera Arencibia Y, Vo M, Kinaga J, Uribe J, Velasquez G, Madruga M, Carlan SJ. Fat embolism and nonconvulsive status epilepticus. Case Rep Neurol Med. 2018, 2018:5057624. 10.1155\/2018\/5057624","journal-title":"Case Rep Neurol Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2021000307","article-title":"Indications for transfusion in the management of sickle cell disease","volume":"2021","author":"Han H","year":"2021","unstructured":"Han H, Hensch L, Tubman VN. Indications for transfusion in the management of sickle cell disease. Hematology Am Soc Hematol Educ Program. 2021, 2021:696-703. 10.1182\/hematology.2021000307","journal-title":"Hematology Am Soc Hematol Educ Program"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/464446-fat-embolization-syndrome-in-sickle-cell-disease-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T09:07:35Z","timestamp":1771060055000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/464446-fat-embolization-syndrome-in-sickle-cell-disease-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,14]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.103578","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,14]]}}}